newsfilter
← Latest News
GlobeNewswire·

Syneos Health Dealmakers' Intentions Survey Sees "Optimism" for M&A and Licensing Deals in 2023

MORRISVILLE, N.C., Jan. 10, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (NASDAQ:SYNH), the only fully integrated biopharmaceutical solutions organization, today released its 13th annual Dealmakers' Intentions Survey.